Skip to content
Nycomed Logo
  • Contact
  • Sitemap
  • Downloads
Nycomed Worldwide Websites
Choose Country
  • Headquarters
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Azerbaijan
  • Belarus
  • Belgium
  • Brazil
  • Canada
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • Georgia
  • Germany
  • Greece
  • Hungary
  • India
  • Italy
  • Kazakhstan
  • Latvia
  • Lithuania
  • Mexico
  • Netherlands
  • Norway
  • Poland
  • Russia
  • Slovakia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • Ukraine
  • United Kingdom
  • United States
  • Uzbekistan
 
 
  • Home
  • About Us
  • Partnerships
  • Research and Development
  • Products
  • Manufacturing
  • Media
  • Investors
  • Careers
 
  • You are here:
  • Home
  • Sitemap
 

Sitemap

About Us
  • Management
    • Executive Management Committee
    • Board of Directors
  • Our Culture & Values
  • Facts & Figures
  • Downloads
  • Corporate Responsibility
  • Our Milestones
  • Our Strategy
  • Nycomed Worldwide
    • Europe
    • Russia and CIS
    • Americas
    • Asia-Pacific
    • Africa and Middle East
Partnerships
  • Partnering with Nycomed
  • Examples of Our Success in Partnering
    • Licensing
    • Mergers & Acquisitions
  • What We Bring to the Partnership
  • Contacts & Events
  • What We Are Looking for
Research and Development
  • R&D Strategy
  • Pipeline
    • Registration
    • Phase III
    • Phase II
    • Phase I
  • Clinical Trials Registry and Disclosure
Products
  • Gastrointestinal
    • Pantoprazole
    • Riopan®
    • Eparema®
    • Hepatalgina®
  • Osteoporosis
    • Calcium D3
    • Preotact®
  • Respiratory
    • Daxas®
    • Alvesco®
    • Omnaris®
    • Curosurf®
    • Zymelin®/Xymelin®
    • Febrisan®
    • Amol®
  • Tissue Management
    • TachoSil®
  • Pain Management
    • Matrifen®
    • Neosaldina®
    • Xefo®
    • Instanyl®
    • Ibumetin®
  • Further Therapies
    • Actovegin®
    • Circadin®
Manufacturing
  • Contract Manufacturing
    • Technologies
    • Services
    • Operational Excellence
  • Global Presence
  • Events
Media
  • Press Releases
    • 2010
    • 2009
    • 2008
    • 2007
  • Daxas® (Roflumilast)
    • Background Information
  • Media Resources
    • Publications
  • Subscription
Investors
  • Ownership
  • Financial Calendar
  • Performance Indicators
  • Financial Reports
Careers
  • Who We Are
  • How to Join Us
  • What We Seek
  • What We Offer
    • Compensation and Benefits
    • Career Development
Disclaimer
top of page
© Nycomed, 2010          Nycomed International Management GmbH, Thurgauerstrasse 130, 8152 Glattpark-Opfikon, Zurich, Switzerland
  • Disclaimer